Jens Baumert, Lukas Reitzle, Ralph Brinks, Ronny Kuhnert, Christin Heidemann
{"title":"Trends in prevalence and number of cases of diagnosed type 2 diabetes in Germany: Projections until 2050.","authors":"Jens Baumert, Lukas Reitzle, Ralph Brinks, Ronny Kuhnert, Christin Heidemann","doi":"10.25646/13381","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In order to assess the prevention and care needs for type 2 diabetes in the coming decades from a public health perspective, forecasts on the trends in prevalence and case numbers are essential.</p><p><strong>Methods: </strong>The data are based on age-specific estimates of diagnosed diabetes prevalence from the survey German Health Update (GEDA) 2022, and on the proportion of type 2 diabetes derived from routine health insurance data. Using routine data on the incidence and excess mortality of diabetes, various scenarios for the future trends of type 2 diabetes are modelled using an illness-death model.</p><p><strong>Results: </strong>Based on a type 2 diabetes prevalence of 8.6 % in 2022 (women: 8.2 %, men: 9.2 %), corresponding to a total of 6.05 million cases (women: 2.92 million, men 3.13 million), the prevalence is expected to rise to 16.1 % by 2050 (women: 14.8 %, men: 17.4 %), with the number of cases increasing to 11.01 million (women: 5.19 million, men: 5.82 million). Assuming a 2.0 % annual decline in incidence, the prevalence is expected to rise to only 12.2 % (8.39 million cases); with a simultaneous 2.0 % annual decline in excess mortality, the prevalence is expected to reach 13.0 % (8.94 million cases).</p><p><strong>Conclusions: </strong>The prognosis is mainly influenced by changes in incidence. Primary preventive approaches to reduce risk factors for type 2 diabetes are therefore crucial to counteract an increase in the number of type 2 diabetes cases.</p>","PeriodicalId":73767,"journal":{"name":"Journal of health monitoring","volume":"10 3","pages":"e13381"},"PeriodicalIF":0.0000,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12478463/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of health monitoring","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25646/13381","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: In order to assess the prevention and care needs for type 2 diabetes in the coming decades from a public health perspective, forecasts on the trends in prevalence and case numbers are essential.
Methods: The data are based on age-specific estimates of diagnosed diabetes prevalence from the survey German Health Update (GEDA) 2022, and on the proportion of type 2 diabetes derived from routine health insurance data. Using routine data on the incidence and excess mortality of diabetes, various scenarios for the future trends of type 2 diabetes are modelled using an illness-death model.
Results: Based on a type 2 diabetes prevalence of 8.6 % in 2022 (women: 8.2 %, men: 9.2 %), corresponding to a total of 6.05 million cases (women: 2.92 million, men 3.13 million), the prevalence is expected to rise to 16.1 % by 2050 (women: 14.8 %, men: 17.4 %), with the number of cases increasing to 11.01 million (women: 5.19 million, men: 5.82 million). Assuming a 2.0 % annual decline in incidence, the prevalence is expected to rise to only 12.2 % (8.39 million cases); with a simultaneous 2.0 % annual decline in excess mortality, the prevalence is expected to reach 13.0 % (8.94 million cases).
Conclusions: The prognosis is mainly influenced by changes in incidence. Primary preventive approaches to reduce risk factors for type 2 diabetes are therefore crucial to counteract an increase in the number of type 2 diabetes cases.